Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights

– Received U.S. Food and Drug Administration (“FDA”) Breakthrough Therapy Designation (“BTD”) for CYB003, its proprietary deuterated psilocybin analog in development for the adjunctive treatment of Major Depressive Disorder (“MDD”) –

– Clinical site selection complete for Phase 3 multinational

Industry leaders reveal the marketing power of word-of-mouth in Reddit’s new B2B campaign

In ‘The Reddit Recommendation Engine,’ marketers from leading holding companies discuss how the platform’s genuine user recommendations hold unique marketing value in a landscape dominated by curated content and paid endorsements.

In an era where influencer culture and celebrity endorsements …

Back To Top